BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 944093)

  • 1. A characterization of the immunosuppressive activity of adriamycin and daunomycin on humoral antibody production and tumor allograft rejection.
    Vecchi A; Mantovani A; Tagliabue A; Spreafico F
    Cancer Res; 1976 Apr; 36(4):1222-7. PubMed ID: 944093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of adriamycin and daunomycin on antitumoral immune effector mechanisms in an allogeneic system.
    Mantovani A; Vecchi A; Tagliabue A; Spreafico F
    Eur J Cancer (1965); 1976 May; 12(5):371-9. PubMed ID: 954795
    [No Abstract]   [Full Text] [Related]  

  • 3. Steroid contraceptive agents and immunological reactivity in experimental animals.
    Vecchi A; Tagliabue A; Mantovani A; Anaclerio A; Barale C; Spreafico F
    Biomedicine; 1976; 24(4):231-7. PubMed ID: 1086685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo cytotoxicity of adriamycin and daunomycin for murine macrophages.
    Mantovani A
    Cancer Res; 1977 Mar; 37(3):815-20. PubMed ID: 837378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunodepressive and hematotoxic activities of N-trifluoro-acetyl-adriamycin-14-valerate.
    Vecchi A; Spreafico F; Sironi M; Cairo M; Garattini S
    Eur J Cancer (1965); 1980 Oct; 16(10):1289-96. PubMed ID: 7202463
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of host defense merchanisms in the antitumor activity of adriamycin and daunomycin in mice.
    Mantovani A; Polentarutti N; Luini W; Peri G; Spreafico F
    J Natl Cancer Inst; 1979 Jul; 63(1):61-6. PubMed ID: 286835
    [No Abstract]   [Full Text] [Related]  

  • 7. Synergism in immunosuppression. 3. Allograft rejection and humoral antibody production in intact and splenectomized mice.
    Gelfand MC; Nowakowski A; Friedman EA; Knepshield JH
    Transplantation; 1971 Nov; 12(5):377-83. PubMed ID: 4948689
    [No Abstract]   [Full Text] [Related]  

  • 8. T killer cells play a role in allogeneic bone marrow graft rejection but not in hybrid resistance.
    Dennert G; Anderson CG; Warner J
    J Immunol; 1985 Dec; 135(6):3729-34. PubMed ID: 3905963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dynamics of the immunodepressive and antitumor activity of adriamycin].
    Vereina TL; Turishchev VE; Gavrilova AD; Matveev AB
    Farmakol Toksikol; 1986; 49(1):73-5. PubMed ID: 3948992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunosuppressive properties of vinblastine and colchicine].
    Leont'eva TI; Maksimova GF; Babichev VA; Uteshev BS
    Tsitologiia; 1977 Feb; 19(2):186-91. PubMed ID: 18824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA breaks in P288 tumor cells in mice after treatment with daunorubicin and adriamycin.
    Schwartz HS
    Res Commun Chem Pathol Pharmacol; 1975 Jan; 10(1):51-64. PubMed ID: 1124321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FTY720 inhibits TH1-mediated allogeneic humoral immune response.
    Peñuelas-Rivas G; Domínguez-Perles R; Brinkmann V; Del Rio ML; Muñoz-Luna A; Ramírez-Romero P; Parrilla-Paricio P; Rodríguez-Barbosa JI
    Transplant Proc; 2005 Nov; 37(9):4124-6. PubMed ID: 16386642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake of adriamycin and daunomycin in L1210 and human leukemia cells: a comparative study.
    Chervinsky DS; Wang JJ
    J Med; 1976; 7(1):63-79. PubMed ID: 1064679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative characteristics of the antitumor and immunodepressive activity of carminomycin on the L-1210 experimental model].
    Berezina TA; Uteshev BS
    Antibiotiki; 1979 Oct; 24(10):767-71. PubMed ID: 496420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contrary action of khingamin on the rejection of a skin allograft and on the level of antibody-producing cells in mice].
    Gamburg LIu; Cheredeev AN
    Biull Eksp Biol Med; 1987 Jun; 103(6):727-30. PubMed ID: 3297194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective immunosuppression by drugs in balanced immune responses.
    Heppner GH; Griswold DE; Di Lorenzo J; Poplin EA; Calabresi P
    Fed Proc; 1974 Aug; 33(8):1882-5. PubMed ID: 4602113
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative study of antineoplastic and immunosuppressive properties of ftorafur].
    Nosova TA; Babichev VA; Uteshev BS
    Farmakol Toksikol; 1976; 39(5):589-93. PubMed ID: 800767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of iodobenzoteph and cytostasan on several immune responses in animals].
    Pykhtina AA
    Farmakol Toksikol; 1978; 41(6):719-23. PubMed ID: 82518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of bone marrow allograft rejection and hybrid resistance in nonresponder recipients by antibody: is there evidence for a dual receptor interaction in acute marrow graft rejection?
    Dennert G; Anderson CG; Warner J
    J Immunol; 1986 Jun; 136(11):3981-6. PubMed ID: 3517162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The response of C3H mice to an L1210 tumor allograft.
    Nevalainen DE
    Res Commun Chem Pathol Pharmacol; 1974 Apr; 7(4):771-4. PubMed ID: 4828768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.